Anika Therapeutics Inc (ANIK)
16.97
-0.46
(-2.64%)
USD |
NASDAQ |
Nov 22, 16:00
17.02
+0.05
(+0.29%)
After-Hours: 20:00
Anika Therapeutics Revenue (Quarterly): 38.75M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 38.75M |
| June 30, 2024 | 41.92M |
| March 31, 2024 | 40.52M |
| December 31, 2023 | 42.97M |
| September 30, 2023 | 41.46M |
| June 30, 2023 | 44.30M |
| March 31, 2023 | 37.92M |
| December 31, 2022 | 39.62M |
| September 30, 2022 | 40.26M |
| June 30, 2022 | 39.66M |
| March 31, 2022 | 36.69M |
| December 31, 2021 | 35.82M |
| September 30, 2021 | 39.54M |
| June 30, 2021 | 38.14M |
| March 31, 2021 | 34.29M |
| December 31, 2020 | 32.69M |
| September 30, 2020 | 31.69M |
| June 30, 2020 | 30.68M |
| March 31, 2020 | 35.40M |
| December 31, 2019 | 29.77M |
| September 30, 2019 | 29.70M |
| June 30, 2019 | 30.42M |
| March 31, 2019 | 24.72M |
| December 31, 2018 | 26.96M |
| September 30, 2018 | 26.79M |
| Date | Value |
|---|---|
| June 30, 2018 | 30.55M |
| March 31, 2018 | 21.26M |
| December 31, 2017 | 29.39M |
| September 30, 2017 | 27.18M |
| June 30, 2017 | 33.46M |
| March 31, 2017 | 23.39M |
| December 31, 2016 | 28.73M |
| September 30, 2016 | 25.79M |
| June 30, 2016 | 26.58M |
| March 31, 2016 | 22.28M |
| December 31, 2015 | 30.89M |
| September 30, 2015 | 23.68M |
| June 30, 2015 | 22.90M |
| March 31, 2015 | 15.52M |
| December 31, 2014 | 23.25M |
| September 30, 2014 | 22.06M |
| June 30, 2014 | 26.27M |
| March 31, 2014 | 34.01M |
| December 31, 2013 | 21.25M |
| September 30, 2013 | 17.75M |
| June 30, 2013 | 20.83M |
| March 31, 2013 | 15.25M |
| December 31, 2012 | 22.61M |
| September 30, 2012 | 14.77M |
| June 30, 2012 | 19.62M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
29.77M
Minimum
Dec 2019
44.30M
Maximum
Jun 2023
37.61M
Average
38.45M
Median
Revenue (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 14.67M |
| Xtant Medical Holdings Inc | 27.94M |
| Myomo Inc | 9.208M |
| Catheter Precision Inc | 0.096M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.92M |
| Total Expenses (Quarterly) | 63.67M |
| EPS Diluted (Quarterly) | -2.03 |
| Enterprise Value | 186.17M |
| Gross Profit Margin (Quarterly) | 3.72% |
| Profit Margin (Quarterly) | -77.20% |
| Earnings Yield | -39.19% |
| Normalized Earnings Yield | -13.27 |